You are leaving Medscape Education
Cancel Continue
News & Perspective
Drugs & Diseases
CME & Education
Academy
Video
Decision Point

Specialty: Multispecialty
Allergy & Immunology
Anesthesiology
Business of Medicine
Cardiology
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Medicine
Gastroenterology
General Surgery
Hematology - Oncology
HIV/AIDS
Hospital Medicine
Infectious Diseases
Internal Medicine
Multispecialty
Nephrology
Neurology
Ob/Gyn & Women's Health
Oncology
Ophthalmology
Orthopedics
Pathology & Lab Medicine
Pediatrics
Plastic Surgery
Psychiatry
Public Health
Pulmonary Medicine
Radiology
Rheumatology
Transplantation
Urology
Interprofessional
Shared Decision Making
Nurses
Pharmacists
Edition: English

Medscape

English
Deutsch
Español
Français
Português
UKNew

Univadis

Sign Up It's Free!
English Edition

Medscape

Univadis

    X
    Univadis from Medscape

    No Results

      Tuesday, December 5, 2023
      News & Perspective Drugs & Diseases CME & Education Academy Video Decision Point
      Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
       
       

       

       

      CME / CE

      Show What You Know: Optimizing Diagnosis and Management of Bipolar Depression

      • Authors: Megan Breuer, PhD; Clinton W. Wright, PharmD, BCPP
      • CME / CE Released: 11/9/2023
      • Valid for credit through: 11/9/2024, 11:59 PM EST
      Start Activity

      • Credits Available

        Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s)™

        Nurses - 0.25 ANCC Contact Hour(s) (0.25 contact hours are in the area of pharmacology)

        IPCE - 0.25 Interprofessional Continuing Education (IPCE) credit

        You Are Eligible For

        • Letter of Completion

      Target Audience and Goal Statement

      This activity is intended for psychiatrists, primary care physicians (PCPs), neurologists, and related specialty-focused nurse practitioners (NPs), physician assistants (PAs), nurses, pharmacists, and other healthcare professionals (HCPs) involved in the care of patients with bipolar disorder. 

      The goal of this activity is for learners to be better able to assess their baseline knowledge related to the diagnosis of bipolar depression and to increase their knowledge of clinical data regarding therapies to treat bipolar depression.

      Upon completion of this activity, participants will:

      • Have increased knowledge regarding the
        • Clinical data for therapies to treat bipolar depression
      • Self-assess learning needs related to
        • Using validated tools for screening/diagnosis of bipolar depression

      Disclosures

      Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

      All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

      Disclosures for additional planners can be found here.

      Faculty

      • Megan Breuer, PhD

        Medical Writer
        Medscape, LLC

        Disclosures

        Megan Breuer, PhD, has no relevant financial relationships.

      • Clinton W. Wright, PharmD, BCPP

        Medical Education Director
        Medscape, LLC

        Disclosures

        Clinton W. Wright, PharmD, BCPP, has no relevant financial relationships.

      Compliance Reviewer/Nurse Planner

      • Leigh Schmidt, MSN, RN, CNE, CHCP

        Associate Director, Accreditation and Compliance, Medscape, LLC

        Disclosures

        Leigh Schmidt, MSN, RN, CNE, CHCP, has no relevant financial relationships.

      Accreditation Statements

      Medscape

      Interprofessional Continuing Education

      In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

      IPCE

      This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit for learning and change.

        For Physicians

      • Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

        College of Family Physicians of Canada Mainpro+® participants may claim certified credits for any AMA PRA Category 1 credit(s)™, up to a maximum of 50 credits per five-year cycle. Any additional credits are eligible as non-certified credits. College of Family Physicians of Canada (CFPC) members must log into Mainpro+® to claim this activity.

        Contact This Provider

        For Nurses

      • Awarded 0.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.25 contact hours are in the area of pharmacology.

        Contact This Provider

      For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

      Instructions for Participation and Credit

      There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

      This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit(s)™, you must receive a minimum score of 75% on the post-test.

      Follow these steps to earn CME/CE credit*:

      1. Read about the target audience, learning objectives, and author disclosures.
      2. Study the educational content online or print it out.
      3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

      You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

      *The credit that you receive is based on your user profile.

      < The Future Is Friendly: Advances in Managing Top Psychiatric Conditions
      From Medscape Education Family Medicine
      CME / CE

      Show What You Know: Optimizing Diagnosis and Management of Bipolar Depression

      Authors: Megan Breuer, PhD; Clinton W. Wright, PharmD, BCPPFaculty and Disclosures

      CME / CE Released: 11/9/2023

      Valid for credit through: 11/9/2024, 11:59 PM EST

      processing....

      References

      1. McIntyre RS, et al. The Rapid Mood Screener (RMS): a novel and pragmatic screener for bipolar I disorder. Curr Med Res Opin. 2021;37:135-144.
      2. McIntyre RS, et al. Bipolar depression: the clinical characteristics and unmet needs of a complex disorder. Curr Med Res Opin. 2019;35:1993-2005.
      3. Zimmerman M, et al. Screening for bipolar disorder with the Mood Disorders Questionnaire: a review. Harv Rev Psychiatry. 2011;19:219-228.
      4. Baldessarini RJ, et al. Bipolar depression: a major unsolved challenge. Int J Bipolar Disord. 2020;8:1.
      5. Rolin D, et al. Is it depression or is it bipolar depression? J Am Assoc Nurse Pract. 2020;32:703-713.
      6. McIntyre RS, et al. The efficacy of lumateperone in patients with bipolar depression with mixed features. J Clin Psychiatry. 2023a;84:22m14739.
      7. McIntyre RS, et al. The efficacy of lumateperone on symptoms of depression in bipolar I and bipolar II disorder: Secondary and post hoc analyses. Eur Neuropsychopharmacol. 2023b;68:78-88.
      8. Post RM. Treatment of bipolar depression evolving recommendations. Psychiatr Clin North Am. 2016;39:11-33.
      9. Suttajit S, et al. Quetiapine for acute bipolar depression: a systematic review and meta-analysis. Drug Des Devel Ther. 2014;8:827-838.
      « Return to: Show What You Know: Optimizing Diagnosis and Management of Bipolar Depression
      CME / CE Information
      • Print
      Find Us On
      About
      About Medscape Privacy Policy Editorial Policy Cookies Terms of Use Advertising Policy Help Center
      Membership
      Become a Member About You Professional Information Newsletters & Alerts Market Research
      App
      Medscape
      WebMD Network
      Medscape Live Events WebMD MedicineNet eMedicineHealth RxList WebMD Corporate Medscape UK
      Editions
      English Deutsch Español Français Português UK
      All material on this website is protected by copyright, Copyright © 1994-2023 by WebMD LLC. This website also contains material copyrighted by 3rd parties.